Recombinant Human Cathepsin D Protein (His tag) (Active) is a Human Full Length protein, in the 21 to 412 aa range, with >=95% purity, <= 0.005 EU/µg endotoxin level and suitable for HPLC, MS, SDS-PAGE.
L V R I P L H K F T S I R R T M S E V G G S V E D L I A K G P V S K Y S Q A V P A V T E G P I P E V L K N Y M D A Q Y Y G E I G I G T P P Q C F T V V F D T G S S N L W V P S I H C K L L D I A C W I H H K Y N S D K S S T Y V K N G T S F D I H Y G S G S L S G Y L S Q D T V S V P C Q S A S S A S A L G G V K V E R Q V F G E A T K Q P G I T F I A A K F D G I L G M A Y P R I S V N N V L P V F D N L M Q Q K L V D Q N I F S F Y L S R D P D A Q P G G E L M L G G T D S K Y Y K G S L S Y L N V T R K A Y W Q V H L D Q V E V A S G L T L C K E G C E A I V D T G T S L M V G P V D E V R E L Q K A I G A V P L I Q G E Y M I P C E K V S T L P A I T L K L G G K G Y K L S P E D Y T L K V S Q A G K T L C L S G F M G M D I P P P S G P L W I L G D V F I G R Y Y T V F D R D N N R V G F A E A A R L
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application HPLC | Reactivity Reacts | Dilution info - | Notes - |
Application MS | Reactivity Reacts | Dilution info - | Notes - |
Application SDS-PAGE | Reactivity Reacts | Dilution info - | Notes - |
Acid protease active in intracellular protein breakdown. Plays a role in APP processing following cleavage and activation by ADAM30 which leads to APP degradation (PubMed:27333034). Involved in the pathogenesis of several diseases such as breast cancer and possibly Alzheimer disease.
CPSD, CTSD, Cathepsin D
Recombinant Human Cathepsin D Protein (His tag) (Active) is a Human Full Length protein, in the 21 to 412 aa range, with >=95% purity, <= 0.005 EU/µg endotoxin level and suitable for HPLC, MS, SDS-PAGE.
The specific activity is ≥ 500 pmol/min/ug.
pH: 7.4
Constituents: 10.26% Trehalose, 0.727% Dibasic monohydrogen potassium phosphate, 0.248% Potassium phosphate monobasic
SDS-PAGE >= 95%
Acid protease active in intracellular protein breakdown. Plays a role in APP processing following cleavage and activation by ADAM30 which leads to APP degradation (PubMed:27333034). Involved in the pathogenesis of several diseases such as breast cancer and possibly Alzheimer disease.
Belongs to the peptidase A1 family.
N- and O-glycosylated.
This product is an active protein and may elicit a biological response in vivo, handle with caution.
Cathepsin D also known as CTSD is a protein with a mass of approximately 45 kDa. It functions as an aspartyl protease and is expressed in lysosomes across various tissues including the liver and kidneys. This enzyme acts by cleaving peptide bonds within proteins which is essential for protein degradation and turnover. Cathepsin D exists as precursor forms that become activated in the acidic environment of the lysosome. It plays a critical role in normal cellular processes by maintaining protein homeostasis.
The enzymatic activity of Cathepsin D is important for cellular maintenance and apoptosis. This protease does not act within larger protein complexes but contributes to the degradation of extracellular and intracellular proteins. It mediates processes like antigen processing where it deconstructs proteins into peptides that are presented on major histocompatibility complex (MHC) molecules. ELISA tests can quantify its expression levels sometimes termed as CTSD activity in various biological samples offering insights into its role within cellular environments.
Cathepsin D involvement includes the lysosomal degradation pathway and the apoptotic signaling pathway. In the lysosomal degradation pathway Cathepsin D breaks down proteins and peptides a process important for cellular recycling and energy release. It interacts with other lysosomal enzymes such as Cathepsin B in this pathway ensuring comprehensive breakdown of cellular waste. The apoptotic signaling pathway involves the regulation of programmed cell death where Cathepsin D can influence the activation of downstream proteins like Bcl-2 and Bax which control cell survival.
The overexpression of Cathepsin D links to breast cancer and Alzheimer's disease. In breast cancer increased Cathepsin D expression correlates with tumor progression and metastasis influencing tumor behavior through interactions with other proteins involved in cell proliferation. Alzheimer's disease features the involvement of Cathepsin D in the breakdown of amyloid precursor protein which relates to amyloid beta plaque accumulation. The abnormal activity of Cathepsin D in these disorders makes it a potential target for therapeutic antibodies such as CTSD antibodies which aim to regulate its function.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Mass determination by ESI-TOF. Predicted MW is 44111.38 Da (+/-10 Da by ESI-TOF). Observed MW is 44114.14 Da.
Fully active determined by its ability to cleave fluorogenic peptide substrate Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 (Mca-PLGL-Dap(Dnp)-AR-NH2).
The specific activity is ≥ 500 pmol/min/ug.
SDS-PAGE analysis of ab307480
HPLC analysis of ab307480
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com